Articles
06.09.2021
Real world evidence

Real-world evidence (RWE) refers to clinical and economic evidence which has been derived from the a...

Read more
Articles
01.09.2021
England's new integrated care systems

Integrated Care Systems (ICS) have been designed to enable health and care organisations to join for...

Read more
Articles
30.08.2021
Blockbuster drugs of the next decade

Until June 30th, 2021, the FDA in the US and European Medicine Agency in Europe have launched 32 and...

Read more
Articles
06.08.2021
Healthcare performance comparison summary

The Common Wealth Fund has recently released a healthcare performance comparison report between 11 c...

Read more
Articles
04.08.2021
ICER puts spotlight on health insurers

ICER recently outlined its plans to annually assess Barriers to Fair Access within prescription drug...

Read more
News
04.08.2021
PMA Insights: Week 31 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
News
19.07.2021
PMA Insights: Week 29

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
19.07.2021
Aduhelm The Story So Far

Aduhelm is the first drug to be approved by the FDA that claims to treat Alzheimer's disease rather ...

Read more
Articles
07.07.2021
Gene therapy market access and pricing trends

A dive into the complex and expensive world of gene therapy pricing and access.

Read more
Articles
28.06.2021
COVID-19 pandemic shaping industry

One year after the first lockdown was announced in the UK we take a brief look at trends and changes...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.